Virological evolution in HIV treatment-experienced patients with raltegravir-based salvage regimens

被引：0
|
作者：
Katlama, C. [1 ]
Caby, F. [1 ]
Andrade, R. M. [1 ]
Schneider, L. [1 ]
Canestri, A. [1 ]
Ktroza, N. [1 ]
Tubiana, R. [1 ]
Valantin, M. A. [1 ]
Wirden, M. [2 ]
Mallet, I. [2 ]
Calvez, V. [2 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[2] Hop La Pitie Salpetriere, Dept Virol, Paris, France
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [21] HIV DNA viral load evolution under a raltegravir-based therapy
    Charpentier, C.
    Piketty, C.
    Laureillard, D.
    Tisserand, P.
    Weiss, L.
    Belec, L.
    Si-Mohamed, A.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A21 - A21
  • [22] Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection
    Eron, Joseph J.
    Cooper, David A.
    Steigbigel, Roy T.
    Clotet, Bonaventura
    Yeni, Patrick
    Strohmaier, Kim M.
    Rodgers, Anthony J.
    Barnard, Richard J.
    Nguyen, Bach-Yen T.
    Teppler, Hedy
    ANTIVIRAL THERAPY, 2015, 20 (03) : 307 - 315
  • [23] Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1-Infected Patients in Switzerland
    Elbasha, E. E.
    Szucs, T.
    Chaudhary, M. A.
    Kumar, R. N.
    Roediger, A.
    Cook, J. R.
    Opravil, M.
    HIV CLINICAL TRIALS, 2009, 10 (04): : 233 - 253
  • [24] Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
    Calcagno, A.
    Marinaro, L.
    Nozza, S.
    Aldieri, C.
    Carbone, A.
    Ghisetti, V.
    Trentalange, A.
    D'Avolio, A.
    Castagna, A.
    Di Perri, G.
    Bonora, S.
    ANTIVIRAL RESEARCH, 2014, 108 : 44 - 47
  • [25] COST-MINIMIZATION ANALYSIS OF ETRAVIRINE AND RALTEGRAVIR, TWO NEW HIV TREATMENTS FOR TREATMENT-EXPERIENCED PATIENTS
    Martin, S. C.
    VALUE IN HEALTH, 2008, 11 (06) : A438 - A438
  • [26] Factors associated with virological response to raltegravir in experienced HIV-infected patients
    Marcelin, A. G.
    Delaugerre, C.
    Flandre, P.
    Descamps, D.
    Morand-Joubert, L.
    Amiel, C.
    Ferre, V.
    Izopet, J.
    Masquelier, B.
    Calvez, V.
    ANTIVIRAL THERAPY, 2011, 16 : A74 - A74
  • [27] Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects
    Capetti, Amedeo F.
    De Socio, Giuseppe, V
    Cossu, Maria, V
    Sterrantino, Gaetana
    Cenderello, Giovanni
    Cattelan, Annamaria
    Baldin, Gian M.
    Soria, Alessandro
    Riccardi, Niccolo
    Niero, Fosca P.
    Celesia, Benedetto M.
    Barbarini, Giorgio
    Rusconi, Stefano
    Rizzardini, Giuliano
    HIV CLINICAL TRIALS, 2018, 19 (06): : 242 - 248
  • [28] Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Carlos Dominguez-Hermosillo, Juan
    Chavez-Garcia, Marcelino
    Isaac Banda-Lara, Marco
    Nunez-Rodriguez, Nohemi
    Enrique Cruz-Herrera, Javier
    Luis Sandoval-Ramirez, Jorge
    Martinez-Abarca, Ivan
    Francisco Villagomez-Ruiz, Alfredo
    Manjarrez-Tellez, Bulmaro
    Gaytan-Martinez, Jesus
    AIDS RESEARCH AND THERAPY, 2015, 12
  • [29] Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients
    Carlos Dominguez-Hermosillo, Juan
    Antonio Mata-Marin, Jose
    Estela Herrera-Gonzalez, Norma
    Chavez-Garcia, Marcelino
    Huerta-Garcia, Gloria
    Nunez-Rodriguez, Nohemi
    Gerardo Garcia-Gamez, Jose
    Jimenez-Romero, Anai
    Enrique Gaytan-Martinez, Jesus
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (09): : 982 - 987
  • [30] Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
    Vicente Escudero Vilaplana
    Sergio Plata Paniagua
    Nicolas Trovato Lopez
    Isabel Castillo Romera
    Arantza Ais Larisgoitia
    Jose Maria Bellon Cano
    Maria Sanjurjo Saez
    Retrovirology, 7
12345